UCB SA

UCBJY·OTC Markets OTCPK·Healthcare
Compare
114.46−1.00 (−0.87%)today
At close: Oct 16, 3:57 PM EDT · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close115.46
Open115.15
Day range114.35115.28
52-week range110.55168.76
Off day high−0.71%
Off 52-week high−32.18%
Volume6.76K
Avg. volume (3M)48.00K
Market cap43.58B
EPS (TTM)6.60
Forward P/E15.03
P/E ratio (TTM)17.34
Dividend yield0.74% (0.8500)
Beta (5Y)0.19
Shares outstanding380.72M
Short interest—
Earnings dateJul 31, 2025
Analyst target161.40
Profit margin25.74%

Against its peers

Compare in full ›
UCBJY ROIV JAZZ TGTX ZLAB LGND
Market cap 43.58B 24.22B 13.65B 8.26B 2.60B 5.89B
P/E (TTM) 17.3 — 14.4 19.6 — 31.1
Forward P/E 15.0 -19.5 8.1 19.9 -11.0 24.7
Price/book 3.3 5.7 2.8 12.7 4.3 6.1
Dividend yield 0.74% — — — — —
1-year change −20.89% +89.01% +55.90% +53.67% −19.31% +58.26%
Today −0.87% −1.50% −1.95% −3.63% −1.36% −0.99%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All UCBJY news ›
The Daily Star·Positive

UCB holds RMG conclave to promote sustainable industry

The United Commercial Bank PLC (UCB) recently organised a business conclave with senior garment and textile industry representatives to promote export competitiveness, energy security and sustainability challenges facing the sector. The…

Place Midlands·

UCB launches Brocks as part of £15m hospitality plan

20 October 2026 , 8:00 - 12:00 19 November 2026 , 8:00 - 12:00 2 December 2026 , 12:30 - 3:00 28 January 2027 , 8:00 - 12:00 4 February 2027 , 8:30 - 6:30 11 February 2027 , 12:30 - 3:30 22 April 2027 , 8:30 - 6:30 18 May 2027 , 8:30 -…

MarketScreener·Negative

FDA green light for UCB and positive view from DB

Belgian biopharmaceutical group UCB has announced that the US FDA has approved a new administration option for Zilbrysq (zilucoplan), its treatment for generalized myasthenia gravis in adult patients with anti-acetylcholine receptor (AChR)…

@genbio·Positive

UCB Dedicates Future U.S. Biologics Manufacturing Campus in Georgia

~330 jobs to be based at $2B, ~460,000-square-foot campus in Gwinnett County A rendering of the Rowen, GA, site where UCB plans to build a $2 billion biologics manufacturing campus that is set to open as the Belgian-based drug developer’s…

From articles in the 4Search news index.

In the news

39mentions in 30 days
39with it in the headline
Positivesentiment

Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 39 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.